Can silver diamine fluoride reduce invasive treatments with general anesthesia?


Journal

The Journal of clinical pediatric dentistry
ISSN: 1557-5268
Titre abrégé: J Clin Pediatr Dent
Pays: Singapore
ID NLM: 9100079

Informations de publication

Date de publication:
Sep 2024
Historique:
received: 07 12 2023
accepted: 11 01 2024
medline: 14 9 2024
pubmed: 14 9 2024
entrez: 14 9 2024
Statut: ppublish

Résumé

This study aims to retrospectively evaluate the differences in dental treatments rendered in general anesthesia (GA) for patients who did or did not receive application of silver diamine fluoride (SDF) prior to GA. 1559 patients (≤6 years) who completed treatment with GA for caries at University of California San Francisco (UCSF) between 2015 and 2019 were included in the study. At baseline patients' electronic health record was reviewed to collect planned treatment, complete dental treatment and demographics. Patients were identified as SDF group (N = 335, 21.49%) or comparison (N = 1224, 78.51%). Dental treatments rendered were compared between the SDF and comparison group with multi-variable regression, including variables for demographics and clinical findings at baseline. The initial analysis identified variations in gender, age, dental pain, pulp involvement, and initial treatment plans between the SDF and comparison groups at baseline. In an unadjusted analysis, the SDF group displayed a statistically significant increase in the number of crown procedures but a notable decrease in the number of pulp therapy and extraction treatments completed (

Identifiants

pubmed: 39275835
pii: S1053-4628(24)00200-5
doi: 10.22514/jocpd.2024.117
doi:

Substances chimiques

silver diamine fluoride DDU19UEV1Y
Fluorides, Topical 0
Silver Compounds 0
Quaternary Ammonium Compounds 0
Cariostatic Agents 0

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

174-182

Informations de copyright

©2024 The Author(s). Published by MRE Press.

Déclaration de conflit d'intérêts

The authors declare no conflict of interest.

Auteurs

Jean Marie Star (JM)

Department of Orofacical Sciences, University of California San Francisco, San Francisco, CA 94143, USA.

Pardis Lipkin (P)

Department of Orofacical Sciences, University of California San Francisco, San Francisco, CA 94143, USA.

Kristin S Hoeft (KS)

Department of Orofacical Sciences, University of California San Francisco, San Francisco, CA 94143, USA.

Jing Cheng (J)

Department of Preventive and Restorative Dental Sciences, University of California San Francisco, San Francisco, CA 94143, USA.

Ling Zhan (L)

Department of Orofacical Sciences, University of California San Francisco, San Francisco, CA 94143, USA.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH